FLVCR2 Antibody

Code CSB-PA892364ESR2HU
Size US$166
Order now
Image
  • Western blot
    All lanes: FLVCR2 antibody at 0.83µg/ml
    Lane 1: A549 whole cell lysate
    Lane 2: Mouse lung tissue
    Secondary
    Goat polyclonal to rabbit IgG at 1/10000 dilution
    Predicted band size: 58, 36 kDa
    Observed band size: 58 kDa

  • Immunohistochemistry of paraffin-embedded human testis tissue using CSB-PA892364ESR2HU at dilution of 1:100

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) FLVCR2 Polyclonal antibody
Uniprot No.
Target Names
FLVCR2
Alternative Names
FLVCR2 antibody; C14orf58Feline leukemia virus subgroup C receptor-related protein 2 antibody; Calcium-chelate transporter antibody; CCT antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human Feline leukemia virus subgroup C receptor-related protein 2 protein (1-100AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated
Clonality
Polyclonal
Isotype
IgG
Purification Method
Antigen Affinity Purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Form
Liquid
Tested Applications
ELISA, WB, IHC
Recommended Dilution
Application Recommended Dilution
WB 1:1000-1:5000
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Acts as an importer of heme. Also acts as a transporter for a calcium-chelator complex, important for growth and calcium metabolism.
Gene References into Functions
  1. Mutations in FLVCR2 associated with Fowler syndrome and survival beyond infancy PMID: 25677735
  2. Mutations in FLVCR2 gene are responsible for Proliferative vasculopathy and Hydranencephaly-hydrocephaly syndrome. FLVCR2 transporter is gatekeeper for the controlled entry of calcium into cell, and involves the regulation of calcium metabolism. PMID: 25906927
  3. FLVCR2 mutation is associated with Hydranencephaly. PMID: 25131804
  4. High-throughput sequence data identified mutations and a large deletion in the FLVCR2 gene casuing lethal cerebral vasculopathy. PMID: 20690116
  5. Results report the cellular function of FLVCR2 as an importer of heme. PMID: 20823265
  6. Direct sequencing of candidate genes within the target interval in chromosome 14q24.3 revealed five different germline mutations in FLVCR2 in five families with Fowler syndrome. PMID: 20206334

Show More

Hide All

Involvement in disease
Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH)
Subcellular Location
Cell membrane; Multi-pass membrane protein.
Protein Families
Major facilitator superfamily, Feline leukemia virus subgroup C receptor (TC 2.A.1.28.1) family
Tissue Specificity
Expressed in non-hematopoietic tissues, with relative abundant expression in brain, placenta, lung, liver and kidney. Also expressed in hematopoietic tissues (fetal liver, spleen, lymph node, thymus, leukocytes and bone marrow). Found in acidophil cells o
Database Links

HGNC: 20105

OMIM: 225790

KEGG: hsa:55640

STRING: 9606.ENSP00000238667

UniGene: Hs.509966

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*